SEC Form 4 · accession 0001628280-18-003727
NEOGENOMICS INC · NEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sharon Virag
Officer — Chief Financial Officer
Period of report
Mar 27, 2018
Accepted (ET)
Mar 28, 2018 · 4:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001077183
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $8.22 | Mar 27, 2018 | A | 192,500 | A | Mar 27, 2019 | Mar 27, 2023 | Common Stock | 192,500 | 192,500 | D |
Explanation of responses
- F1On March 27, 2018, Ms. Virag was granted an option to purchase shares of NeoGenomics, Inc. common stock. The option vests ratably over the first three anniversary dates of the grant date.